IDH1 and acute myeloid leukemia: However, it has been shown that somatic mutations in the active site of IDH1/2 in AML cells lead to the overproduction of the oncometabolite 2-D-hydroxyglutarate, which blocks differentiation and contributes to AML progression (65).